 ?您的位置：對照品 > 對照品 > 國家對照品 > |
|
|
|
| 產(chǎn)品基本信息 |
|
| 產(chǎn)品編號：C227940 |
| 產(chǎn)品名稱：CCT196969 |
| 產(chǎn)品CAS：1163719-56-9 |
| 規(guī)格含量：50mg |
| 產(chǎn)品價格：面議 |
| 聯(lián)系我們: |
 |
|
 |
|
|
| 產(chǎn)品詳細介紹 |
| 標準品編號: |
C227940 |
| 名稱: |
CCT196969 |
| 別名: |
N-[4-[(3,4-Dihydro-3-oxopyrido[2,3-b]pyrazin-8-yl)oxy]-2-fluorophenyl]-N'-[3-(1,1-dimethylethyl)-1-phenyl-1H-pyrazol-5-yl]urea |
| CAS號: |
1163719-56-9 |
| 分子式: |
C??H??FN?O? |
| 分子量: |
513.52 |
| 類別: |
Standards; Enzyme Activators and Inhibitors; Pharmaceutical/API Drug Impurities/Metabolites; |
| 應(yīng)用: |
CCT196969 is a paradox-breaking RAF inhibitor that also targets SRC and is thus effective in drug-resistant BRAF mutant melanoma. |
| 參考文獻 |
|
|
|
|
|
|
